PharVision Advisers’s El Pollo Loco LOCO Stock Holding History

PharVision Advisers’s Portfolio LOCO Stock Details LOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,757	Closed	-$133K	–	408
2025 Q4	$133K	Buy	+12,757	New	+$132K	0.07%	631
2025 Q2	–	Sell	-12,892	Closed	-$133K	–	364
2025 Q1	$133K	Sell	12,892 -14,826	-53%	-$168K	0.18%	236
2024 Q4	$320K	Buy	+27,718	New	+$349K	0.27%	130

Other funds holding LOCO

BCC

Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

PharVision Advisers's LOCO Position: Q1 2026 in Review

PharVision Advisers sold out of El Pollo Loco (LOCO) in Q1 2026, closing a stake of 12,757 shares — an estimated $133K sold.

PharVision Advisers first reported a position in LOCO in Q4 2024 and held it in 3 quarters. The position peaked at $320K in Q4 2024. 142 funds tracked by Wall St. Rank hold LOCO as of Q1 2026.

PharVision Advisers reported no remaining El Pollo Loco position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 12,757 El Pollo Loco shares in Q1 2026, an estimated $133K.
PharVision Advisers first reported a position in El Pollo Loco in Q4 2024 and held it in 3 quarters.
PharVision Advisers's El Pollo Loco position peaked at $320K in Q4 2024.
142 funds tracked by Wall St. Rank held El Pollo Loco as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.